» Articles » PMID: 3023320

The Hydrolysis of Extracellular Adenine Nucleotides by Cultured Endothelial Cells from Pig Aorta. Feed-forward Inhibition of Adenosine Production at the Cell Surface

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1986 Nov 25
PMID 3023320
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The time course of the extracellular reaction sequence ATP----ADP----AMP----adenosine has been examined during recirculation of substrate solutions over cultured pig aortic endothelial cells attached to polystyrene beads. This permits the study of reactions at volume to cell surface ratios approaching those of small blood vessels. When endothelial cells were presented with an initial bolus of ATP, high concentrations of the intermediates ADP and AMP developed before significant conversion of AMP to adenosine occurred. Further, the higher the initial ATP concentration, the slower the conversion of AMP to adenosine. Kinetic constants for each reaction were estimated by fitting simulated reaction curves to observed time courses. Apparent Km values estimated in this way agreed well with those reported for initial velocity measurements (ATPase = 300 microM; ADPase = 240 microM; and 5'-nucleotidase = 26 microM). The ratio of maximum velocities was ATPase:ADPase:AMPase = 6:1.5:1, with absolute values varying among cell batches. The data could only be fitted if the model incorporated inhibition of 5'-nucleotidase by ATP or ADP, and satisfactory fitting was achieved with a Ki value for ADP of 5 microM. These kinetic properties maximize the time separation of the intermediate pools. In vivo, at sites of platelet degranulation, they would create a time gap proportional to the size of the initial release between release of ADP (a proaggregatory milieu) and the appearance of adenosine (an anti-aggregatory milieu).

Citing Articles

Stimulation of natural killer cells with small molecule inhibitors of CD38 for the treatment of neuroblastoma.

Mills C, Benton T, Pina I, Francis M, Reyes L, Dolloff N Chem Sci. 2023; 14(8):2168-2182.

PMID: 36845935 PMC: 9945084. DOI: 10.1039/d2sc05749b.


Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation.

Benton T, Mills C, Turner J, Francis M, Solomon D, Burger P RSC Adv. 2022; 11(53):33260-33270.

PMID: 35497564 PMC: 9042253. DOI: 10.1039/d1ra06266b.


CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy.

Horenstein A, Bracci C, Morandi F, Malavasi F Front Immunol. 2019; 10:760.

PMID: 31068926 PMC: 6491463. DOI: 10.3389/fimmu.2019.00760.


Regulation of the T Cell Response by CD39.

Takenaka M, Robson S, Quintana F Trends Immunol. 2016; 37(7):427-439.

PMID: 27236363 PMC: 5215082. DOI: 10.1016/j.it.2016.04.009.


A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes.

Horenstein A, Chillemi A, Zaccarello G, Bruzzone S, Quarona V, Zito A Oncoimmunology. 2013; 2(9):e26246.

PMID: 24319640 PMC: 3850273. DOI: 10.4161/onci.26246.